Clinical Trials Directory

Trials / Completed

CompletedNCT00460044

ADMA and Mechanical Ventilation in Preterm Infants

Plasma ADMA Concentrations at Birth and Mechanical Ventilation in Preterm Infants

Status
Completed
Phase
Study type
Observational
Enrollment
35 (planned)
Sponsor
Amsterdam UMC, location VUmc · Academic / Other
Sex
All
Age
32 Weeks
Healthy volunteers
Not accepted

Summary

The purpose of this study is to study the relation between mechanical ventilation and ADMA concentrations at birth.

Detailed description

Nitric oxide (NO) plays an important role in the normal development and maturation of the lungs. In addition, NO is an important mediator of vascular smooth muscle relaxation, ventilation perfusion matching, neurotransmission and host defence and bacteriostasis. Asymmetric dimethylarginine (ADMA) is an endogenous derivative of arginine that inhibits NOS and thereby the bioavailability of NO. Preterm infants have increased concentrations of ADMA. Therefore, inhibition of NO by increased concentrations of ADMA which could be associated with reduced pulmonary functioning.

Conditions

Timeline

Start date
2002-01-01
Completion
2003-07-01
First posted
2007-04-13
Last updated
2007-04-13

Source: ClinicalTrials.gov record NCT00460044. Inclusion in this directory is not an endorsement.